Zymeron
Zymeron is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative healthcare technologies that deliver step-change performance. The company focuses on proactive health solutions to address critical unmet needs in the pharmaceutical sciences, particularly in drug delivery and formulation technologies.
Industries
Nr. of Employees
small (1-50)
Zymeron
400 Park Offices Drive, STE 211 PO Box 12072 Research Triangle Park, NC 27709
Patents
Immunoassay platform for the serological discrimination of closely related viruses
2025-01-14 • US-12196755-B2
View Details
Immunoassay platform for the serological discrimination of closely related viruses
2025-01-14 • US-12196755-B2
View DetailsProducts
Bone marrow-targeted myeloprotective therapeutic (preclinical)
Preclinical injectable drug program that delivers cytoprotective molecules to hematopoietic stem and progenitor cells to prevent chemotherapy- or radiation-induced myelosuppression.
Rapid lab-on-chip sterility testing system (rapid microbiological method)
Automated, closed-system lab-on-chip sterility test providing qualitative presence/absence results in under 30 minutes with single-cell sensitivity and non-destructive sample handling.
Long-acting subcutaneous prophylactic drug implant (preclinical)
Biodegradable subcutaneous implant technology intended to provide customizable-duration prophylaxis (1–12 months) for infectious disease prevention without requiring surgical removal.
Dual biologic–small molecule wound therapeutics
Extracellular vesicle-based wound therapy program for biofilm management, antimicrobial activity, and wound healing promotion, developed with companion diagnostic and sterility testing components.
Bone marrow-targeted myeloprotective therapeutic (preclinical)
Preclinical injectable drug program that delivers cytoprotective molecules to hematopoietic stem and progenitor cells to prevent chemotherapy- or radiation-induced myelosuppression.
Rapid lab-on-chip sterility testing system (rapid microbiological method)
Automated, closed-system lab-on-chip sterility test providing qualitative presence/absence results in under 30 minutes with single-cell sensitivity and non-destructive sample handling.
Long-acting subcutaneous prophylactic drug implant (preclinical)
Biodegradable subcutaneous implant technology intended to provide customizable-duration prophylaxis (1–12 months) for infectious disease prevention without requiring surgical removal.
Dual biologic–small molecule wound therapeutics
Extracellular vesicle-based wound therapy program for biofilm management, antimicrobial activity, and wound healing promotion, developed with companion diagnostic and sterility testing components.
Expertise Areas
- Myeloprotection and chemoprotection
- Bone marrow-targeted drug delivery
- Injectable formulation and reformulation
- Long-acting implantable drug delivery
Key Technologies
- Peptide drug conjugates for targeted delivery
- Extracellular vesicle-mediated delivery
- Lab-on-chip microfluidics
- Miniaturized automated instrumentation
Key People
Not specified
Not specified
Not specified
Not specified
News & Updates
Zymeron Corporation announced that its myelotoxicity drug program is boosted by a $3.0M federal funding to advance its lead drug candidate in preclinical studies.
Zymeron Corporation announced that it received multi-year funding from the Department of Defense to continue its development of a long-lasting antimalaria prophylactic drug.
Zymeron Corporation announced that it has relocated to the Frontier Campus Building 400, Research Triangle Park, NC, providing renovated dynamic laboratory spaces for startups.
Zymeron Corporation announced that its myelotoxicity drug program is boosted by a $3.0M federal funding to advance its lead drug candidate in preclinical studies.
Zymeron Corporation announced that it received multi-year funding from the Department of Defense to continue its development of a long-lasting antimalaria prophylactic drug.
Zymeron Corporation announced that it has relocated to the Frontier Campus Building 400, Research Triangle Park, NC, providing renovated dynamic laboratory spaces for startups.